Center-Authored Papers

Filters: Author is Brown, Elizabeth R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhang J, Brown ER.  2014.  Estimating the effectiveness in HIV prevention trials by incorporating the exposure process: Application to HPTN 035 data.. Biometrics. Abstract
W
Watts HD, Brown ER, Maldonado Y, Herron C, Chipato T, Reddy L, Moodley D, Nakabiito C, Manji K, Fawzi W et al..  2013.  HIV Disease Progression in the First Year after Delivery among African Women followed in the HPTN 046 Clinical Trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
T
Teeple EA, Brown ER.  2015.  Adjusting for time-dependent sensitivity in an illness-death model, with application to mother-to-child transmission of HIV.. Statistics in medicine. 34(8):1277-92. Abstract
S
van der Straten A, Mayo A, Brown ER, Amico RK, Cheng H, Laborde N, Marrazzo J, Torjesen K.  2015.  Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial.. AIDS and behavior. 19(5):770-83. Abstract
van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, Marzinke MA, Piper JM, Hendrix CW.  2016.  Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.. Journal of the International AIDS Society. 19(1):20642. Abstract
R
Roxby AC, Drake AL, John-Stewart G, Brown ER, Matemo D, Otieno PA, Farquhar C.  2011.  Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women.. PloS one. 6(5):e19947. Abstract
P
Palanee-Phillips T, Schwartz K, Brown ER, Govender V, Mgodi N, Kiweewa FM, Nair G, Mhlanga F, Siva S, Bekker L-G et al..  2015.  Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.. PloS one. 10(6):e0128857. Abstract
M
Murnane PM, Brown ER, Donnell D, Coley YR, Mugo N, Mujugira A, Celum C, Baeten JM.  2015.  Estimating Efficacy in a Randomized Trial With Product Nonadherence: Application of Multiple Methods to a Trial of Preexposure Prophylaxis for HIV Prevention.. American journal of epidemiology. 182(10):848-856. Abstract
Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A.  2016.  Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? AIDS and behavior. Abstract
Mehta S, Manji KP, Young AM, Brown ER, Chasela C, Taha TE, Read JS, Goldenberg RL, Fawzi WW.  2008.  Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women.. The American journal of clinical nutrition. 87(6):1639-49. Abstract
L
Liang JC, Budoff MJ, Kaufman JD, Kronmal RA, Brown ER.  2012.  An alternative method for quantifying coronary artery calcification: the multi-ethnic study of atherosclerosis (MESA).. BMC medical imaging. 12(1):14. Abstract
H
Husnik MJ, Brown ER, Marzinke M, Livant E, Palanee-Phillips T, Hendrix C, Kiweewa FM, Nair G, Soto-Torres LE, Schwartz K et al..  2017.  Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
Hanscom B, Janes HE, Guarino PD, Huang Y, Brown ER, Chen YQ, Hammer SM, Gilbert PB, Donnell DJ.  2016.  Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence.. Journal of acquired immune deficiency syndromes (1999). Abstract
Hanscom B, Janes HE, Guarino PD, Huang Y, Brown ER, Chen YQ, Hammer SM, Gilbert PB, Donnell DJ.  2016.  Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence.. Journal of acquired immune deficiency syndromes (1999). 73(5):606-608. Abstract
F
Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K et al..  2012.  Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-Infected Breastfeeding Infants.. The Pediatric infectious disease journal. Abstract
D
Dimitrov D, Boily M-C, Marrazzo J, Beigi R, Brown ER.  2013.  Population-Level Benefits from Providing Effective HIV Prevention Means to Pregnant Women in High Prevalence Settings.. PloS one. 8(9):e73770. Abstract
Dimitrov D, Boily M-C, Brown ER, Hallett TB.  2013.  Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.. PloS one. 8(11):e80927. Abstract
Dimitrov D, Donnell D, Brown ER.  2015.  High incidence is not high exposure: what proportion of prevention trial participants are exposed to HIV? PloS one. 10(1):e0115528. Abstract
Dezzutti CS, Brown ER, Moncla B, Russo J, Cost M, Wang L, Uranker K, Kunjara Na Ayudhya RP, Pryke K, Pickett J et al..  2012.  Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PloS one. 7(11):e48328. Abstract
Dezzutti CS, Yandura S, Wang L, Moncla B, Teeple EA, Devlin B, Nuttall J, Brown ER, Rohan LC.  2015.  Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention.. Pharmaceutical research. 32(11):3768-3781. Abstract
Dai JY, Gilbert PB, Hughes JP, Brown ER.  2013.  Estimating the Efficacy of Preexposure Prophylaxis for HIV Prevention Among Participants With a Threshold Level of Drug Concentration.. American journal of epidemiology. 177(3):256-63. Abstract
Dai JY, Hendrix CW, Richardson BA, Kelly C, Marzinke M, Chirenje MZ, Marrazzo JM, Brown ER.  2016.  Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.. The Journal of infectious diseases. 213(3):335-342. Abstract
C
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W et al..  2012.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.. Lancet. 379(9812):221-8. Abstract
Coley RY, Brown ER.  2016.  Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model.. Statistics in medicine. Abstract
Choi RY, Fowke KR, Juno J, Lohman-Payne B, Oyugi JO, Brown ER, Bosire R, John-Stewart G, Farquhar C.  2011.  C868T Single Nucleotide Polymorphism and HIV Type 1 Disease Progression Among Postpartum Women in Kenya.. AIDS research and human retroviruses. Abstract